ArticleRestorative dentistry & endodontics2021
Biocompatibility and bioactive potential of the NeoMTA Plus endodontic bioceramic-based sealer.
Article in Restorative dentistry & endodontics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Biocompatibility and bioactivity of bioceramic endodontic sealer: NeoSealer Flo.Journal of applied oral science : revista FOB · 2025Article
- The osteoinductive potential of different root-end filling materials in a rat femur modelScientific reports · 2024Article
- Tissue Reaction Elicited by Neosealer Flo, AH 26, and CC Sealer in Rats : Tissue Reaction of CC Sealer.Galen medical journal · 2024Article
- Calcium Silicate-Based Sealer Dentinal Tubule Penetration-A Systematic Review of In Vitro Studies.Materials (Basel, Switzerland) · 2023Review
- Bioactivity Potential of Bioceramic-Based Root Canal Sealers: A Scoping Review.Life (Basel, Switzerland) · 2022Article
- An Updated Review on Properties and Indications of Calcium Silicate-Based Cements in Endodontic Therapy.International journal of dentistry · 2022Review
- Review
- Tissue repair capacity of bioceramic endodontic sealers in rat subcutaneous tissue.Brazilian dental journalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study evaluated the biocompatibility and bioactive potential of NeoMTA Plus mixed as a root canal sealer in comparison with MTA Fillapex. MATERIALS AND
methodsPolyethylene tubes filled with NeoMTA Plus (
resultsAt 7 days, the capsules around NeoMTA Plus and MTA Fillapex had more ICs and IL-6-immunostained cells than the CG. However, at 60 days, there was no significant difference in the IC number between NeoMTA Plus and the CG (
conclusionsThe NeoMTA Plus root canal sealer is biocompatible and exhibits bioactive potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.